NCT06760546Phase 3Recruiting

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-03-13Estimated

Enrollment · participants39Estimated

Source updated2026-02-12Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-02-12 · 1 field changed

Primary completion date changed

− Before

~~30 Sep 2026~~

+ After

13 Mar 2027

Check registry source

Posted 2025-10-20 · 1 field changed

Primary completion date changed

− Before

~~30 Jan 2027~~

+ After

30 Sep 2026

Check registry source